Although the rate of CD204- CD68+ monocyte cells per DOG-1+ tumour cell did not differ by clinical setting (p = 0.16; Fig. 2f), the rate of CD204+ CD68+ monocytes per DOG-1+ cell was significantly higher in IM-PD/SU-treated group compared to TKI-naive (p = 0.004) and IM-PD groups (p = 0.01; Fig. 2g). This evidence concerns the gene MSR1 and neoplasm.